A phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | McDermott, D. F.; Infante, J. R.; Chowdhury, S.; Voss, M. H.; Motzer, R. J.; Perini, R. F.; Morosky, A.; Zheng, F. F.; White, B. C.; Wang, Q.; Jewell, R. C.; Rini, B. I. |
| Abstract Title: | A phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S519 |
| End Page: | S520 |
| Language: | English |
| ACCESSION: | WOS:000361887402325 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31440-X |
| Notes: | Meeting Abstract: 2622 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
